1. Nada Benhima, Leila Afani, Mohammed El Fadli, Ismail Essâdi and Rhizlane Belbaraka Investigating the availability, affordability, and market dynamics of innovative oncology drugs in Morocco: an original report. International Journal for Equity in Health (2024) 23:217 https://doi.org/10.1186/s12939-024-02262-9

 2. Ganiou Adjadé , Kelly Haag , Jérôme Meunier, Mohammed El Fadli , Ismail Essadi, Rhizlane Belbaraka. Giant cell arteritis and therapeutic response: a dual facet of immunotherapy in metastatic clear cell renal carcinoma. Oxford Medical Case Reports, 2024, 7, 324–326 https://doi.org/10.1093/omcr/omae082

 3. Nada Benhima; Khalid El Bairi; Mohammed El Fadli and Rhizlane Belbaraka, Building a United Front: Radiation Oncologists as Collaborative Partners, Not Competitors, to Medical Oncologists. JCO Global Oncol (June 2024) 10:e240019

 4. Nada Benhima, Mohammed El Fadli, et al, Pazopanib induced trismus in a young male with metastatic renal cell carcinoma: Case report and literature review. Oxford Medical Case reports. 2023(12). https://doi.org/10.1093/omcr/omad146. 

5. Ganiou Adjadé, Hassan Abdelilah Tafenzi, Houda Jouihri, Nadin Shawar Al TamimiYousra Bennouna, Gustave Négamiyimana, Kalil Cisse, Ismail Essadi, Mohammed El Fadli and Rhizlane Belbaraka. Localised breast cancer: neoadjuvant chemotherapy impact evaluation on the pathological complete response (PCR) in a lower middle-income country . ecancer 2023, 17:1648 https://orcid.org/0000-0003-0768-7493 

6. Edwin Kelly Haag, Ganiou Adjadé, Héba Dawood, Mohammed El Fadli, Ismail Essadi and Rhizlane Belbaraka. Severe and fatal interstitial lung disease induced bygemcitabine in advanced pancreatic adenocarcinoma: a case report . Oxford Medical Case Reports, 2023, 11, 410–412 DOI: 10.1093/omcr/omad120

7. Tafenzi HA, Choulli F, Adjade G, Baladi A, Afani L, Fadli ME, Essaadi I, Belbaraka R. Development of a well-defined tool to predict the overall survival in lung cancer patients: an African based cohort.BMC Cancer. 2023 Oct 20;23(1):1016. doi: 10.1186/s12885-023-11355-7 

8. Mohammed El Fadli, Ganiou Adjade, et al. A therapeutic challenge in an elderly woman and spectacular clinical response to an unusual left supra-clavicular metastasis of ovarian adenocarcinoma. August 2023. Journal of Clinical Images and Medical Case Reports. 10.52768/2766-7820/2439

9. Al Tamimi NS, Bennouna Y, El Fadli M, Belbaraka R. Metastatic Small Cell Carcinoma of a Male Breast: A Case Report and Review of the Literature Gulf J Oncolog. 2023 May;1(42):74-78

10. Kaakoua M, Boufdil A, El Fadli M, Belbaraka R, Essadi I. Eighteen Years of Medical Oncology in Morocco: A Bibliometric Evaluation. Cureus. 2023 May 9;15(5):e38766 doi:10.7759/cureus.38766 

11. Mohammed El Fadli, Nada Benhima, et al. Serous cystadenocarcinoma of the testis: case report of a rare entity. October 2022. African Journal of Urology. https://doi.org/10.1186/s12301 022-00324-4.

12. Nada Benhima, Mohammed El Fadli, et al. What does it take to conduct clinical trials in African countries? Insights from Morocco 10.3332/ecancer.2022.1411. .Juin2022.Ecancermedicalscience.

13. Justin Bagorane , Gustave Negamiyimana , Juvénal Kwizera , Manon Morillon , Ntukamazina Déo , Mohamed El Fadli , Jaafar Bennouna , Rhizlane Belbaraka .Management of cancer disease in Burundi, a health challenge. Bulletin du Cancer 2023 February 110 ( 2 ) : 145-150 

14. Rhizlane Belbaraka, Nada Benhima, El Fadli M,Essadi I. Incidence Trends of Cancer in Morocco: The Tale of the Oncological Center of Marrakech (Morocco) over 8 Years. February 2022. Journal of Cancer Epidemiology. 10.1155/2022/3307194.

15. Justin Bagorane, Mohammed El Fadli et al. Severe acral erythrodysesthesia and docetaxel. April 2021. Our Dermatology Online. 10.7241/ourd.20212.25 

16. Ganiou Adjade, Mohammed El Fadli, et al. Bleomycin-induced flagellate erythema in a patient with germ cell tumor. October 2020. Our Dermatology Online. 10.7241/ourd.2020S3.6 

17. Mohammed El Fadli,Kerrou kheldoun,Jospeh Gligororv . BREAST CANCER METASTASIS TO THE SPLEEN: A CASE REPORT AND LITERATURE REVIEW . Oxford Medical Case Reports, 2017(12),250-252 

18. Impact of tumor location (right vs left) as a prognostic and predictive factor in colon cancer in a Moroccan population: A single-center study. Annals of Oncology July 2020 ; 31:S191 

19. Adjuvant chemotherapy for stage II colon cancer following complete resection: Experience of the Mohammed VI University Hospital Centre oncology center in Marrakech. Annals of Oncology July 2020 ; 31:S197 

20. Gastrointestinal stromal tumors: 10 years of experience in the medicaloncology department at Mohammed VI university hospital in Marrakech, Morocco . Annals of Oncology July 2020 ; 31:S187-S188 

21. EGFR-inhibitors in metastatic wild-type RAS colorectal cancer: Experience of the oncology department of Mohammed VI University Hospital in Marrakech. Annals of Oncology July 2020 ; 31:S206

22. Perioperative chemotherapy versus surgery alone on resectable advanced gastric cancer in a Moroccan population.Annals of Oncology July 2020 ; 31:S191

23. Bevacizumab in Moroccan patients with metastatic colorectal cancer. Annals of Oncology; Jun2014, Vol. 25 Issue suppl_2, pii64

24. Assessment of sunitinib alternative prescription schedules in metastatic kidney cancer: A study of 10 cases within the Oncology/Hematology center of Med VI University Hospital Center, Marrakech. Gulf Journal of Oncology : 2018 (26):3